文献速递细菌感染、耐药与抗菌药物医院感染防控

雾化黏菌素使用与ICU黏菌素耐药的时间关联:时间序列分析

Temporal association between aerosolized colistin use and colistin resistance in the ICU: a time-series analysis.
PubMed 文献 · J Antimicrob Chemother · 2026-01-01

双变量VAR分析显示雾化黏菌素与后续肺炎克雷伯菌和鲍曼不动杆菌耐药增加正相关;多变量模型含其他抗菌药物类别时肺炎克雷伯菌关联持续;VECM敏感性分析四种病原均显著。结论为雾化黏菌素使用与主要革兰阴性病原耐药增加存在时间关联,尤其肺炎克雷伯菌和鲍曼不动杆菌。

要点

  • 雾化黏菌素用量与后续肺炎克雷伯菌、鲍曼不动杆菌黏菌素耐药增加呈正相关
  • 多变量模型纳入其他抗菌药物后,肺炎克雷伯菌的关联仍持续存在
  • 应谨慎使用吸入黏菌素,并将其纳入靶向抗菌药物管理

核心结论

  • 雾化黏菌素使用与主要革兰阴性病原黏菌素耐药增加存在时间关联,尤其肺炎克雷伯菌和鲍曼不动杆菌。
  • 结果提示应谨慎使用吸入黏菌素,并支持将其纳入靶向抗菌药物管理以应对耐药风险。

研究设计与样本

  • 场所为2700张床位三级医院的ICU,含108张成人ICU床位。
  • 按平稳性和协整性情况选用向量自回归(VAR)或向量误差 correction 模型(VECM)。

主要发现

  • 双变量VAR分析中,雾化黏菌素使用与后续黏菌素耐药肺炎克雷伯菌和鲍曼不动杆菌增加正相关,多个滞后阶显著。
  • 含其他抗菌药物类别的多变量VAR模型中,肺炎克雷伯菌的时间关联持续存在。
  • VECM敏感性分析显示大肠埃希菌、肺炎克雷伯菌、铜绿假单胞菌和鲍曼不动杆菌均存在显著关联。
  • 对非呼吸道标本的附加分析中,雾化黏菌素也与黏菌素耐药鲍曼不动杆菌显著相关。

临床怎么用

  • 在ICU使用雾化黏菌素时应评估耐药风险,尤其关注肺炎克雷伯菌和鲍曼不动杆菌。
  • 可将吸入黏菌素用量纳入抗菌药物管理监测与干预目标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Aerosolized colistin has been increasingly used to treat multidrug-resistant gram-negative infections, particularly in the intensive care unit (ICU), as an alternative to intravenous colistin, which is limited by nephrotoxicity and poor pulmonary penetration. Systemic colistin use has been linked to the emergence of resistance, but the impact of inhaled colistin on resistance development remains unclear. METHODS: We conducted a time-series analysis using monthly data from April 2014 to December 2023 in the ICUs of a 2700-bed tertiary-care hospital comprising 108 adult ICU beds. Monthly antibiotic use and the incidence of colistin-resistant Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii from respiratory specimens were analysed using vector autoregressive (VAR) or vector error correction models (VECMs), depending on the presence of stationarity and cointegration. RESULTS: In bivariate VAR analyses, aerosolized colistin use was positively associated with subsequent increases in colistin-resistant K. pneumoniae and A. baumannii, with significant effects observed across multiple lags. In multivariate VAR models including other antibiotic classes, the temporal association persisted for K. pneumoniae. Sensitivity analyses using VECM also showed significant associations for E. coli, K. pneumoniae, P. aeruginosa and A. baumannii. In an additional analysis of non-respiratory specimens, aerosolized colistin was also significantly associated with colistin-resistant A. baumannii. CONCLUSIONS: Aerosolized colistin use was temporally associated with increased resistance in major gram-negative pathogens, particularly K. pneumoniae and A. baumannii. These findings highlight the need for cautious use of inhaled colistin and support its inclusion in targeted antimicrobial stewardship efforts, given its potential contribution to the emergence of resistance.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Kang W, Kang W, Son Y, et al. Temporal association between aerosolized colistin use and colistin resistance in the ICU: a time-series analysis. J Antimicrob Chemother. 2026. PMID: 42148779. doi:10.1093/jac/dkag169

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。